Breast cancer patients with lobular cancer more commonly have a father than a mother diagnosed with cancer

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Ellberg, Carolina ^a   Olsson, Håkan ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GENETICS; CANCER INVASION; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; LEUKEMIA; LUNG CANCER; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDULLARY CARCINOMA; MUCINOUS CARCINOMA; PROSTATE CANCER; SARCOMA; STATISTICAL SIGNIFICANCE; TUMOR SUPPRESSOR GENE; AGE; BREAST TUMOR; FATHER; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; RISK; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, LOBULAR; FATHERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROSTATIC NEOPLASMS; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 82155186110     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-497     Document Type: Article

References (26)

1. Reeves GK, Pirie K, Green J, Bull D, Beral V, . Million Women Study C Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis. Br J Cancer 2009, 100(3):538-544. 10.1038/sj.bjc.6604853, 2658546, 19190634, Million Women Study C.
2. Zanetti-Dallenbach RA, Krause EM, Lapaire O, Gueth U, Holzgreve W, Wight E. Impact of hormone replacement therapy on the histologic subtype of breast cancer. Arch Gynecol Obstet 2008, 278(5):443-449. 10.1007/s00404-008-0613-8, 18335229.
3. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266(5182):66-71. 10.1126/science.7545954, 7545954.
4. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995, 378(6559):789-792. 10.1038/378789a0, 8524414.
5. Lakhani SR. The pathology of hereditary breast cancer. Dis Markers 1999, 15(1-3):113-114.
6. Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 2004, 6(3):R149-156. 10.1186/bcr767, 400666, 15084238.
7. Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LF, de Jong D, Van de Vijver MJ, Van't Veer LJ, Peterse JL. Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol 2008, 216(2):141-150. 10.1002/path.2407, 18720457.
8. Li CI, Anderson BO, Daling JR, Moe RE. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 2003, 289(11):1421-1424. 10.1001/jama.289.11.1421, 12636465.
9. Phipps AI, Li CI, Kerlikowske K, Barlow WE, Buist DS. Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population. Cancer Epidemiol Biomarkers Prev 19(6):1643-1654.
10. Li CI, Daling JR, Malone KE, Bernstein L, Marchbanks PA, Liff JM, Strom BL, Simon MS, Press MF, McDonald JA, et al. Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 2006, 15(5):946-954. 10.1158/1055-9965.EPI-05-0881, 16702375.
11. Allen-Brady K, Camp NJ, Ward JH, Cannon-Albright LA. Lobular breast cancer: excess familiality observed in the Utah Population Database. Int J Cancer 2005, 117(4):655-661. 10.1002/ijc.21236, 15929077.
12. Lorenzo Bermejo J, Hemminki K. Familial association of histology specific breast cancers with cancers at other sites. Int J Cancer 2004, 109(3):430-435. 10.1002/ijc.11713, 14961583.
13. Kaurah P, Huntsman DG. Hereditary Diffuse Gastric Cancer. GeneReviews 1993, Seattle (WA), Pagon RA, Bird TD, Dolan CR, Stephens K.
14. Ellberg C, Jonsson G, Olsson H. Can a phenotype for recessive inheritance in breast cancer be defined?. Familial Cancer 2010, 9(4):525-530. 10.1007/s10689-010-9355-4, 20549370.
15. Loman N, Bladstrom A, Johannsson O, Borg A, Olsson H. Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status. Breast Cancer Res 2003, 5(6):R175-186. 10.1186/bcr632, 314401, 14580253.
16. Hemminki K, Chen B. Familial association of prostate cancer with other cancers in the Swedish Family-Cancer Database. Prostate 2005, 65(2):188-194. 10.1002/pros.20284, 15948149.
17. Zeegers MP, Schouten LJ, Goldbohm RA, van den Brandt PA. A compendium of familial relative risks of cancer among first degree relatives: a population-based study. Int J Cancer 2008, 123(7):1664-1673. 10.1002/ijc.23615, 18623131.
18. Valeri A, Fournier G, Morin V, Morin JF, Drelon E, Mangin P, Teillac P, Berthon P, Cussenot O. Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives. Int J Cancer 2000, 86(6):883-887. 10.1002/(SICI)1097-0215(20000615)86:6<883::AID-IJC20>3.0.CO;2-F, 10842206.
19. Rawal R, Bertelsen L, Olsen JH. Cancer incidence in first-degree relatives of a population-based set of cases of early-onset breast cancer. Eur J Cancer 2006, 42(17):3034-3040. 10.1016/j.ejca.2006.04.025, 16996259.
20. National Board of Health S Cancer incidence in Sweden 2009 = Cancerförekomst i Sverige 2009. 2010, Stockholm: The National Board of Health in Sweden, National Board of Health S.
21. Hyder SM, Nawaz Z, Chiappetta C, Stancel GM. Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res 2000, 60(12):3183-3190.
22. Palmero EI, Achatz MI, Ashton-Prolla P, Olivier M, Hainaut P. Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome. Curr Opin Oncol 2010, 22(1):64-69. 10.1097/CCO.0b013e328333bf00, 19952748.
23. Li FP, Fraumeni JF, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, Miller RW. A cancer family syndrome in twenty-four kindreds. Cancer Research 1988, 48(18):5358-5362.
24. Kong A, Steinthorsdottir V, Masson G, Thorleifsson G, Sulem P, Besenbacher S, Jonasdottir A, Sigurdsson A, Kristinsson KT, Frigge ML, et al. Parental origin of sequence variants associated with complex diseases. Nature 2009, 462(7275):868-874. 10.1038/nature08625, 20016592.
25. Robinson WP. Mechanisms leading to uniparental disomy and their clinical consequences. Bioessays 2000, 22(5):452-459. 10.1002/(SICI)1521-1878(200005)22:5<452::AID-BIES7>3.0.CO;2-K, 10797485.
26. Bender R, Lange S. Adjusting for multiple testing--when and how?. J Clin Epidemiol 2001, 54(4):343-349. 10.1016/S0895-4356(00)00314-0, 11297884.